Human CD20 / MS4A1 Full Length Protein, His Tag (Detergent) (SPR verified)

ユーザーレビュー
製品番号/仕様
価格
数量
CD0-H52H3-20ug
$875.00
CD0-H52H3-100ug
$3080.00
CD0-H52H3-500ug
$7705.00
ETA of in-stock products:2 business days
総アイテム数 製品金額$ 0

製品詳細

  • Application

    1. Immunization
    2. Affinity testing (SPR / BLI)
    3. Screening (ELISA)
  • Synonyms

    MS4A1, CD20, MS4A-1

  • Source

    Detergent Human CD20 Full Length Protein, His Tag (CD0-H52H3) is expressed from human 293 cells (HEK293). It contains AA Met 1 - Pro 297 (Accession # P11836-1).

    Predicted N-terminus: Met 1

    Request for sequence
  • Molecular Characterization

    CD20 Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries a polyhistidine tag at the C-terminus.

    The protein has a calculated MW of 35.2 kDa. The protein migrates as 40 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

    *The DDM/CHS buffer (Cat. No. DC-11) is sold separately and not included in protein, you can follow the link for product information.

    1. Structure

      Each full-length transmembrane protein is encapsulated by detergent micelle.

    2. Synthesis Process

      Through mild detergent micelle extraction, dedicated solubilization, and stringent affinity purification, we maximally retain the native transmembrane conformation of full-length transmembrane proteins throughout downstream purification. This workflow yields purified, detergent-solubilized proteins free of unrelated membrane impurities and exogenous scaffold proteins, with exceptional purity, accurate quantitation, and well-preserved biological activity—ideal for immunization, binding assays in antibody discovery and screening (ELISA) and affinity testing (SPR and BLI), etc.

  • Endotoxin

    Less than 1.0 EU per μg by the LAL method / rFC method.

  • Purity

    >85% as determined by SDS-PAGE.

  • Formulation

    This product is not suitable for cell based experiments due to cytotoxicity of DDM.
    DDM and CHS are INDISPENSABLE to keep membrane protein soluble and active, under no circumstances should you remove DDM and CHS.
    DDM/CHS buffer (DC-11) is sold separately and not included in protein, and please contact us if you need the buffer.
    If glycerol is not compatible with your application, remove glycerol just before the immediate experiment, and NEVER store glycerol-free protein solution.

    Supplied as 0.2 μm filtered solution in 50 mM HEPES, 150 mM NaCl, DDM, CHS, pH7.5 with glycerol as protectant.

    Contact us for customized product form or formulation.

  • Shipping

    This product is supplied and shipped with dry ice, please inquire the shipping cost.

  • Storage

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. The product MUST be stored at -70°C or lower upon receipt;
    2. -70°C for 3 months under sterile conditions.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

お客様はこちらも閲覧

データ表示

  • SDS-PAGE

    CD20 SDS-PAGE

    Human CD20 Full Length Protein, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 85% (With Star Ribbon Pre-stained Protein Marker).

  • Bioactivity-ELISA

     CD20 ELISA

    Immobilized Human CD20 Full Length Protein, His Tag (Cat. No. CD0-H52H3) at 5 μg/mL (100 μL/well) can bind Rituximab (Cat. No. CD0-M36) with a linear range of 0.4-3 ng/mL (QC tested).

    Protocol
  •  CD20 ELISA

    Immobilized Human CD20 Full Length Protein, His Tag (Cat. No. CD0-H52H3) at 5 μg/mL (100 μL/well) can bind Ofatumumab with a linear range of 0.4-6 ng/mL (QC tested).

    Protocol
  •  CD20 ELISA

    Immobilized Human CD20 Full Length Protein, His Tag (Cat. No. CD0-H52H3) at 5 μg/mL (100 μL/well) can bind Biosimilar of Obinutuzumab with a linear range of 1-8 ng/mL (Routinely tested).

    Protocol
  •  CD20 ELISA

    Immobilized Human CD20 Full Length Protein, His Tag (Cat. No. CD0-H52H3 at 1 μg/mL, add Glofitamab and then add Biotinylated Human CD3E&CD3G Heterodimer Protein, His,Avitag&Tag Free (Cat. No. CDG-H82W3) at 1 μg/mL. Detection was performed using HRP-conjugated Streptavidin (Acro, Cat. No. STN-NH913) (Routinely tested).

    Protocol
  • Bioactivity-SPR

     CD20 SPR

    MabThera® (Rituximab) captured on CM5 chip via Anti-human IgG Fc antibodies surface can bind Human CD20 Full Length Protein, His Tag (Cat. No. CD0-H52H3) with an affinity constant of 6.21 nM as determined in a SPR assay (in presence of DDM and CHS) (Biacore 8K) (QC tested).

    Protocol
  •  CD20 SPR

    Ofatumumab captured on CM5 chip via Anti-human IgG Fc antibodies surface can bind Human CD20 Full Length Protein, His Tag (Cat. No. CD0-H52H3) with an affinity constant of 9.63 nM as determined in a SPR assay (in presence of DDM and CHS) (Biacore 8K) (QC tested).

    Protocol
  •  CD20 SPR

    Biosimilar of Obinutuzumab captured on CM5 chip via anti-human IgG Fc antibody can bind Human CD20 Full Length Protein, His Tag (Cat. No. CD0-H52H3) with an affinity constant of 21.5 nM as determined in a SPR assay (in presence of DDM and CHS) (Biacore T200) (Routinely tested).

    Protocol
  •  CD20 SPR

    Human CD20 Full Length Protein, His Tag (Cat. No. CD0-H52H3) captured on CM5 chip via Anti-His antibody can bind MabThera® (Rituximab) with an affinity constant of 0.921 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).

    Protocol
  • Bioactivity-BLI

     CD20 BLI

    Loaded Rituximab on AHC Biosensor, can bind Human CD20 Full Length Protein, His Tag (Cat. No. CD0-H52H3) with an affinity constant of 1.14 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).

    Protocol
  •  CD20 BLI

    Loaded Ofatumumab (Human IgG1) on AHC Biosensor, can bind Human CD20 Full Length Protein, His Tag (Cat. No. CD0-H52H3) with an affinity constant of 0.968 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).

    Protocol

ユーザーレビュー
コメントを投稿

  • A***t2021-11-11
    いいね
    I purchased this CD20 protein in order to test BLI binding of anti-CD20 antibodies. At first, I left out the CHS and DDM, even though Acro's directions were clear about how, when, and why to include these, and the curves did not look good. But then I included the CHS and DDM and the BLI curves were clear and of high quality. It is great to be able to test binding to this tricky membrane protein. Because of Acro's CD20, I was able to compare antibodies and enable decision making.
  • 1***92019-10-23
    いいね
    It was for BLI experiment. Compared to the CD20 protein that I previously purchased from another company, this protein has stronger binding bioactivity. It is impressive that this special membrane protein CD20 can be expressed in full length and has high bioactivity. It would be even better if the price can be slightly cheaper.
  • 1***02019-10-11
    いいね
    Because CD20 is a multi-transmembrane protein, I have tried many vendors but none of the expression was good. I ordered this product for both antibody screening and Elisa many times, and the experiments results have been very good. Everything is perfect except it is a little bit expensive.
もっと見る

バックグランド

A B-lymphocyte surface antigen expressed from pre-B to mature B cells, but absent on plasma cells. It functions as a calcium channel and is a validated immunotherapy target, famously exploited by rituximab for treating B-cell malignancies and autoimmune disorders.

最新の進展

 
医薬品開発の進捗
  • 英語名:

    B-lymphocyte antigen CD20

  • カテゴリ:

  • 市販の医薬品数:

    35 詳細

  • 治験医薬品数:

    132 詳細

  • 最新の開発ステージ:

    Approved

お問い合わせ
医薬品候補ライセンス
他の関連情報
  • 製品情報
  • 製品詳細
  • お客様はこちらも閲覧
  • データ表示
  • ユーザーレビュー
  • 背景
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8